pharmacie et médicaments – Doliprane - Souveraineté de la France

This written question concerns the sovereignty of France in the pharmaceutical sector, specifically regarding the availability and production of essential medicines like Doliprane. It seeks to understand the government's strategy to ensure national independence in medicine supply and address potential vulnerabilities.